Ticker: HALO

Company: HALOZYME THERAPEUTICS INC

Person: Bernadette Connaughton, director

Transaction date: Jan. 5, 2026

Reporting date: Jan. 6, 2026

Average share price: 70.25

Sold 2000.0 shares for 140500.0